BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 15762713)

  • 1. Gold dithiocarbamate derivatives as potential antineoplastic agents: design, spectroscopic properties, and in vitro antitumor activity.
    Ronconi L; Giovagnini L; Marzano C; Bettìo F; Graziani R; Pilloni G; Fregona D
    Inorg Chem; 2005 Mar; 44(6):1867-81. PubMed ID: 15762713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic effects of gold(III) complexes on established human tumor cell lines sensitive and resistant to cisplatin.
    Calamai P; Carotti S; Guerri A; Mazzei T; Messori L; Mini E; Orioli P; Speroni GP
    Anticancer Drug Des; 1998 Jan; 13(1):67-80. PubMed ID: 9474243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemical and biological profiles of novel copper(II) complexes containing S-donor ligands for the treatment of cancer.
    Giovagnini L; Sitran S; Montopoli M; Caparrotta L; Corsini M; Rosani C; Zanello P; Dou QP; Fregona D
    Inorg Chem; 2008 Jul; 47(14):6336-43. PubMed ID: 18572881
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, characterization, and comparative in vitro cytotoxicity studies of platinum(II), palladium(II), and gold(III) methylsarcosinedithiocarbamate complexes.
    Giovagnini L; Ronconi L; Aldinucci D; Lorenzon D; Sitran S; Fregona D
    J Med Chem; 2005 Mar; 48(5):1588-95. PubMed ID: 15743200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gold(III) dithiocarbamate derivatives for the treatment of cancer: solution chemistry, DNA binding, and hemolytic properties.
    Ronconi L; Marzano C; Zanello P; Corsini M; Miolo G; Maccà C; Trevisan A; Fregona D
    J Med Chem; 2006 Mar; 49(5):1648-57. PubMed ID: 16509581
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a new platinum(II) complex with low nephrotoxicity and genotoxicity.
    Marzano C; Bettio F; Baccichetti F; Trevisan A; Giovagnini L; Fregona D
    Chem Biol Interact; 2004 Jun; 148(1-2):37-48. PubMed ID: 15223355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis of a palladium(II)-dithiocarbamate complex: biological assay and nephrotoxicity in rats.
    Trevisan A; Marzano C; Cristofori P; Borella Venturini M; Giovagnini L; Fregona D
    Arch Toxicol; 2002 Jun; 76(5-6):262-8. PubMed ID: 12107643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization studies and cytotoxicity assays of Pt(II) and Pd(II) dithiocarbamate complexes by means of FT-IR, NMR spectroscopy and mass spectrometry.
    Alverdi V; Giovagnini L; Marzano C; Seraglia R; Bettio F; Sitran S; Graziani R; Fregona D
    J Inorg Biochem; 2004 Jun; 98(6):1117-28. PubMed ID: 15149823
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ru(III)-based compounds with sulfur donor ligands: synthesis, characterization, electrochemical behaviour and anticancer activity.
    Giovagnini L; Sitran S; Castagliuolo I; Brun P; Corsini M; Zanello P; Zoleo A; Maniero A; Biondi B; Fregona D
    Dalton Trans; 2008 Dec; (47):6699-708. PubMed ID: 19153618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxic activity of some gold(III) complexes.
    Cossu F; Matovic Z; Radanovic D; Ponticelli G
    Farmaco; 1994 Apr; 49(4):301-2. PubMed ID: 8049012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New cytotoxic and water-soluble bis(2-phenylazopyridine)ruthenium(II) complexes.
    Hotze AC; Bacac M; Velders AH; Jansen BA; Kooijman H; Spek AL; Haasnoot JG; Reedijk J
    J Med Chem; 2003 Apr; 46(9):1743-50. PubMed ID: 12699392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor properties of some 2-[(dimethylamino)methyl]phenylgold(III) complexes.
    Buckley RG; Elsome AM; Fricker SP; Henderson GR; Theobald BR; Parish RV; Howe BP; Kelland LR
    J Med Chem; 1996 Dec; 39(26):5208-14. PubMed ID: 8978849
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed complexes of Pt(II) and Pd(II) with ethylsarcosinedithiocarbamate and 2-/3-picoline as antitumor agents.
    Giovagnini L; Marzano C; Bettio F; Fregona D
    J Inorg Biochem; 2005 Nov; 99(11):2139-50. PubMed ID: 16165215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The synthesis, chemical and biological properties of dichlorido(azpy)gold(III) chloride (azpy=2-(phenylazo)pyridine) and the gold-induced conversion of the azpy ligand to the chloride of the novel tricyclic pyrido[2,1-c][1,2,4]benzotriazin-11-ium cation.
    Garza-Ortiz A; den Dulk H; Brouwer J; Kooijman H; Spek AL; Reedijk J
    J Inorg Biochem; 2007 Nov; 101(11-12):1922-30. PubMed ID: 17637477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New isomeric azine-bridged dinuclear platinum(II) complexes circumvent cross-resistance to cisplatin.
    Komeda S; Kalayda GV; Lutz M; Spek AL; Yamanaka Y; Sato T; Chikuma M; Reedijk J
    J Med Chem; 2003 Mar; 46(7):1210-9. PubMed ID: 12646031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and anticancer activity of gold(I) complexes that contain tri-tert-butylphosphine and dialkyl dithiocarbamate ligands.
    Altaf M; Monim-ul-Mehboob M; Seliman AA; Sohail M; Wazeer MI; Isab AA; Li L; Dhuna V; Bhatia G; Dhuna K
    Eur J Med Chem; 2015 May; 95():464-72. PubMed ID: 25841201
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward the selective delivery of chemotherapeutics into tumor cells by targeting peptide transporters: tailored gold-based anticancer peptidomimetics.
    Kouodom MN; Ronconi L; Celegato M; Nardon C; Marchiò L; Dou QP; Aldinucci D; Formaggio F; Fregona D
    J Med Chem; 2012 Mar; 55(5):2212-26. PubMed ID: 22309237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity of the mixed phosphine gold species chlorotriphenylphosphine-1,3-bis(diphenylphosphino)propanegold(I).
    Caruso F; Rossi M; Tanski J; Pettinari C; Marchetti F
    J Med Chem; 2003 Apr; 46(9):1737-42. PubMed ID: 12699391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.